DUTASTERIDE

Dutasteride inhibits 5‑α‑reductase, reducing DHT levels to treat BPH and hair loss. Side effects include decreased libido, erectile dysfunction, and breast tenderness.

SKU: 410ba7045903 Category: Tag:

Product Description


Mechanism of Action

Dutasteride is a dual 5‑α‑reductase inhibitor (types 1 and 2), blocking conversion of testosterone to dihydrotestosterone (DHT). This reduces androgenic signalling in prostate tissue, hair follicles and sebaceous glands. It lowers DHT levels more profoundly than finasteride.

Benefits and Advantages

Used in androgen‑pathway studies, prostate‑biology modelling, hair‑follicle miniaturization research, and endocrine‑axis inhibition assays.

Side Effects and Risks

Risks include decreased libido, gynecomastia, erectile changes and potential reproductive effects. Handle with potent androgen‑modulator precautions.

Datasheet


Molecular Formula

C27H30F6N2O2

Molecular Weight

528.5 g/mol

CAS Number

164656-23-9

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Insoluble

Purity

Purity information is available upon request (COA).

Synonym

Dutasteride; 164656-23-9; Avodart; Avolve; GG-745

IUPAC/Chemical Name

(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

InChl Key

JWJOTENAMICLJG-QWBYCMEYSA-N

InChl Code

InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/6918296;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download